loadpatents
Patent applications and USPTO patent grants for Medof; M. Edward.The latest application filed is for "method for inhibiting platelet derived growth factor signaling with c3ar or c5ar antibodies".
Patent | Date |
---|---|
METHOD FOR INHIBITING PLATELET DERIVED GROWTH FACTOR SIGNALING WITH C3aR OR C5aR ANTIBODIES App 20220185872 - Medof; M. Edward ;   et al. | 2022-06-16 |
Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies Grant 11,130,801 - Medof , et al. September 28, 2 | 2021-09-28 |
Compositions And Methods Of Treating A T Cell Mediated Disorder App 20210275585 - Medof; M. Edward ;   et al. | 2021-09-09 |
Compositions and methods of treating a T cell mediated disorder Grant 10,933,093 - Medof , et al. March 2, 2 | 2021-03-02 |
Compositions And Methods Of Promoting Wound Healing App 20200062855 - Medof; M. Edward ;   et al. | 2020-02-27 |
Compositions And Methods For Modulating Toll Like Receptor Signal App 20180256646 - Medof; M. Edward ;   et al. | 2018-09-13 |
Compositions And Methods Of Treating A T Cell Mediated Disorder App 20180228843 - Medof; M. Edward ;   et al. | 2018-08-16 |
Compositions and methods of treating T cell mediated disorder Grant 9,937,206 - Medof , et al. April 10, 2 | 2018-04-10 |
Method For Treating Disorders Related To Complement Activation App 20170189366 - Medof; M. Edward ;   et al. | 2017-07-06 |
Method Of Treating T Cell Mediated Disorders App 20170027861 - Medof; M. Edward ;   et al. | 2017-02-02 |
Compositions And Methods Of Treating T Cell Mediated Disorder App 20170014451 - Medof; M. Edward ;   et al. | 2017-01-19 |
Compositions And Methods Of Modulating B Cell Response App 20160362482 - Medof; M. Edward | 2016-12-15 |
Compositions and methods of treating T cell mediated disorder Grant 9,290,736 - Medof , et al. March 22, 2 | 2016-03-22 |
Method Of Treating Cancer App 20150299300 - Medof; M. Edward ;   et al. | 2015-10-22 |
Method of treating cancer Grant 8,940,299 - Medof , et al. January 27, 2 | 2015-01-27 |
Hybrid and chimeric polypeptides that regulate activation of complement Grant 8,932,601 - Medof , et al. January 13, 2 | 2015-01-13 |
Compositions And Method Of Modulating Growth Factor Function App 20120315279 - Medof; M. Edward ;   et al. | 2012-12-13 |
Hybrid And Chimeric Polypeptides That Regulate Activation Of Complement App 20120226020 - Medof; M. Edward ;   et al. | 2012-09-06 |
Compositions And Methods Of Treating T Cell Mediated Disorder App 20120219566 - Medof; M. Edward ;   et al. | 2012-08-30 |
Method Of Treating T Cell Mediated Disorders App 20110182910 - Medof; M. Edward ;   et al. | 2011-07-28 |
Method Of Treating Cancer App 20110135656 - Medof; M. Edward ;   et al. | 2011-06-09 |
Method For Treating Disorders Related To Complement Activation App 20100063146 - Medof; M. Edward ;   et al. | 2010-03-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.